Evaluation of Newly Developed Combination Therapy of Intra-Arterial 5-Fluorouracil and Systemic Pegylated Interferon α-2B for Advanced Hepatocellular Carcinoma with Portal Venous Invasion

被引：0
|
作者：
Sawara, Kei
Kasai, Kazuhiro
Suzuki, Kazuyuki
机构：
来源：
GASTROENTEROLOGY | 2009年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A860 / A860
页数：1
相关论文
共 50 条
  • [1] Evaluation of Newly Developed Combination Therapy of Intra-Arterial 5-Fluorouracil and Systemic Pegylated Interferon α-2B for Advanced Hepatocellular Carcinoma With Portal Venous Invasion
    Kasai, Kazuhiro
    Sawara, Kei
    Suzuki, Kazuyuki
    GASTROENTEROLOGY, 2010, 138 (05) : S812 - S812
  • [2] Evaluation of newly developed combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion: preliminary results
    Kasai, Kazuhiro
    Kuroda, Hidekatsu
    Ushio, Akira
    Sawara, Kei
    Takikawa, Yasuhiro
    Suzuki, Kazuyuki
    HEPATOLOGY RESEARCH, 2009, 39 (02) : 117 - 125
  • [3] Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma
    Kasai, Kazuhiro
    Ushio, Akira
    Kasai, Yukiho
    Sawara, Kei
    Miyamoto, Yasuhiro
    Oikawa, Kanta
    Kuroda, Hidekatsu
    Takikawa, Yasuhiro
    Suzuki, Kazuyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (03) : 221 - 229
  • [4] Combination Therapy of Intra-Arterial 5-Fluorouracil and Systemic Pegylated Interferon α-2B for Advanced Hepatocellular Carcinoma
    Kasai, Kazuhiro
    GASTROENTEROLOGY, 2013, 144 (05) : S1035 - S1036
  • [5] Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma
    Kazuhiro Kasai
    Akira Ushio
    Yukiho Kasai
    Kei Sawara
    Yasuhiro Miyamoto
    Kanta Oikawa
    Hidekatsu Kuroda
    Yasuhiro Takikawa
    Kazuyuki Suzuki
    International Journal of Clinical Oncology, 2011, 16 : 221 - 229
  • [6] Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon a-2b for advanced hepatocellular carcinoma with portal venous invasion
    Kasai, Kazuhiro
    Ushio, Akira
    Kasai, Yukiho
    Sawara, Kei
    Miyamoto, Yasuhiro
    Oikawa, Kanta
    Kuroda, Hidekatsu
    Takikawa, Yasuhiro
    Suzuki, Kazuyuki
    CANCER, 2012, 118 (13) : 3302 - 3310
  • [7] Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma.
    Kasai, Kazuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [8] Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon alpha-2b for advanced hepatocellular carcinoma
    Kasai, Kazuhiro
    Sawara, Kei
    Suzuki, Kazuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [9] Effective Treatment for Advanced Hepatocellular Carcinoma with Portal Venous Invasion using a Combination Therapy of Intra-arterial 5-Fluorouracil and Subcutaneous Pegylated-interferon-alpha-2b
    Mawatari, Hironori
    Kirikoshi, Hiroyuki
    Yoneda, Masato
    Higurashi, Takuma
    Fujita, Koji
    Saito, Satoru
    Inamori, Masahiko
    Takahashi, Hirokazu
    Abe, Yasunobu
    Kubota, Kensuke
    Nakajima, Atsushi
    HEPATO-GASTROENTEROLOGY, 2008, 55 (86-87) : 1776 - 1777
  • [10] Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion
    Obi, S
    Yoshida, H
    Toune, R
    Unuma, T
    Kanda, M
    Sato, S
    Tateishi, R
    Teratani, T
    Shiina, S
    Omata, M
    CANCER, 2006, 106 (09) : 1990 - 1997
12345